Cargando…

Diagnosis of Clostridioides difficile infection by analysis of volatile organic compounds in breath, plasma, and stool: A cross-sectional proof-of-concept study

Clostridioides difficile infection (CDI) is an important infectious cause of antibiotic-associated diarrhea, with significant morbidity and mortality. Current diagnostic algorithms are based on identifying toxin by enzyme immunoassay (EIA) and toxin gene by real-time polymerase chain reaction (PCR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	John, Teny M., Shrestha, Nabin K., Procop, Gary W., Grove, David, Leal, Sixto M., Jacob, Ceena N., Butler, Robert, Dweik, Raed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372889/ https://www.ncbi.nlm.nih.gov/pubmed/34407120 http://dx.doi.org/10.1371/journal.pone.0256259

Ejemplares similares

2010. Volatile Organic Compounds Patterns in Breath, Plasma, and Stool in Patients with Clostridium difficile Infection: A Cross-Sectional Proof of Concept Study
por: John, Teny Mathew, et al.
Publicado: (2018)

Thiol Metabolism and Volatile Metabolome of Clostridioides difficile
por: Biwer, Peter, et al.
Publicado: (2022)

Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection
por: Lee, Ching-Chi, et al.
Publicado: (2021)

Clostridiodes difficile Treatment Guided by Polymerase Chain Reaction Stool Testing Does not Alter Outcomes for Patients With Inflammatory Bowel Disease
por: Chandrabos, Ceena, et al.
Publicado: (2021)

Breath volatile metabolome reveals the impact of dietary fibres on the gut microbiota: Proof of concept in healthy volunteers
por: Neyrinck, Audrey M., et al.
Publicado: (2022)

Detection of Free Toxin B in the Stool of Asymptomatic Clostridioides difficile Carriers by the Cell Cytotoxicity Neutralization Assay
por: Schweitzer, Lorne, et al.
Publicado: (2021)

Detection and molecular characterization of VRE isolates in Slovakia from stool samples positive for Clostridioides difficile toxins
por: Kuzma, Jozef, et al.
Publicado: (2022)

1982. A Diagnostic Stewardship Intervention for Clostridioides difficile: Impact of Stool Toxin Testing on Treatment of Adult Inpatients
por: Moss, Jason, et al.
Publicado: (2019)

Clinical applications of breath testing
por: Paschke, Kelly M, et al.
Publicado: (2010)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Screening of Chorioamnionitis Using Volatile Organic Compound Detection in Exhaled Breath: A Pre-clinical Proof of Concept Study
por: Ophelders, Daan R. M. G., et al.
Publicado: (2021)

Clinical evaluation of a non-purified direct molecular assay for the detection of Clostridioides difficile toxin genes in stool specimens
por: Hara, Toshinori, et al.
Publicado: (2020)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

2567. Effect of Broad vs. Narrow-Spectrum Clostridioides difficile Treatment on Human Stool Bile Acid Composition Over Time
por: Thorpe, Cheleste M, et al.
Publicado: (2019)

Clostridioides difficile Toxin B PCR Cycle Threshold as a Predictor of Toxin Testing in Stool Specimens from Hospitalized Adults
por: Lee, Sean, et al.
Publicado: (2022)

Using a dog’s superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study
por: Bomers, Marije K, et al.
Publicado: (2012)

When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
por: John, Teny M., et al.
Publicado: (2021)

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
por: Ahn, Seung Woo, et al.
Publicado: (2021)

Retrospective Definition of Clostridioides difficile PCR Ribotypes on the Basis of Whole Genome Polymorphisms: A Proof of Principle Study
por: Goyal, Manisha, et al.
Publicado: (2020)

Physician and patient perceptions of fecal microbiota transplant for recurrent or refractory Clostridioides difficile in the first 6 years of a central stool bank
por: Gill, Madeleine, et al.
Publicado: (2020)

Results from the first English stool bank using faecal microbiota transplant as a medicinal product for the treatment of Clostridioides difficile infection
por: McCune, V.L., et al.
Publicado: (2020)

Frequency of Diarrhea, Stool Specimen Collection and Testing, and Detection of Clostridioides Difficile Infection Among Hospitalized Adults in the Muenster/Coesfeld Area, Germany
por: Effelsberg, Natalie, et al.
Publicado: (2022)

Metabolism the Difficile Way: The Key to the Success of the Pathogen Clostridioides difficile
por: Neumann-Schaal, Meina, et al.
Publicado: (2019)

Clostridioides difficile therapeutics: guidelines and beyond
por: Orenstein, Robert, et al.
Publicado: (2019)

Impact of ribotype on Clostridioides difficile diagnostics
por: Rizzardi, Kristina, et al.
Publicado: (2019)

Clostridioides (Clostridium) difficile Pacemaker Infection
por: Berkefeld, Anna, et al.
Publicado: (2020)

Opportunities for Nanomedicine in Clostridioides difficile Infection
por: Wang, Pei-Wen, et al.
Publicado: (2021)

Introduction to the Special Issue on Clostridioides difficile
por: Granata, Guido, et al.
Publicado: (2021)

Epidemiology of Clostridioides difficile in South Africa
por: de Jager, Pieter, et al.
Publicado: (2021)

The repertoire of ABC proteins in Clostridioides difficile
por: Pipatthana, Methinee, et al.
Publicado: (2021)

An Update on Clostridioides difficile Binary Toxin
por: Martínez-Meléndez, Adrián, et al.
Publicado: (2022)

Clostridioides difficile: A diagnostic intervention
por: Alsoubani, Majd, et al.
Publicado: (2022)

Phage therapy for Clostridioides difficile infection
por: Fujimoto, Kosuke, et al.
Publicado: (2022)

Clostridioides difficile, a New “Superbug”
por: Markovska, Rumyana, et al.
Publicado: (2023)

Editorial: Microbial interactions of Clostridioides difficile
por: Goh, Shan, et al.
Publicado: (2023)

Isoprene in the Exhaled Breath is a Novel Biomarker for Advanced Fibrosis in Patients with Chronic Liver Disease: A Pilot Study
por: Alkhouri, Naim, et al.
Publicado: (2015)

1745 Cardiac Abnormalities in Leptospirosis and Prognostic significance of Electro-Cardiographic manifestations – A cross-sectional study from South-India
por: Simi, S, et al.
Publicado: (2014)

Exhaled Breath Analysis Using Selected Ion Flow Tube Mass Spectrometry and Disease Severity in Heart Failure
por: Tang, Wai Hong Wilson, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s09p8nb2qoa8ht9fp47jfi3lp0